Polymorphisms of the PTGDR and LTC4S influence responsiveness to leukotriene receptor antagonists in Korean children with asthma
- PMID: 21307858
- DOI: 10.1038/jhg.2011.3
Polymorphisms of the PTGDR and LTC4S influence responsiveness to leukotriene receptor antagonists in Korean children with asthma
Abstract
Activation of the prostaglandin D2 receptor (PTGDR) may contribute to pulmonary vasodilation, bronchoconstriction, recruitment of eosinophils, basophils and T-lymphocytes, and enhanced synthesis of leukotriene C4. We investigated whether polymorphisms of the leukotriene C4 synthase (LTC4S) -444A/C and PTGDR -441T/C were associated with clinical phenotypes and responsiveness to leukotriene receptor antagonist (LTRA) in Korean asthmatic children. We enrolled 270 normal and 870 asthmatic children. We prescribed montelukast (5 mg per day) to 100 of asthmatic children, and analyzed the responsiveness to LTRA by exercise challenge tests. Polymorphisms were genotyped by PCR-restriction fragment length polymorphism. As the number of minor alleles of the PTGDR -441T/C and LTC4S -444A/C polymorphisms increased, the log total eosinophil counts increased in atopic asthmatic children (P-value=0.03). We found a significant association between responsiveness to montelukast and the PTGDR polymorphism (P-value=0.038). However, the LTC4S -444A/C and PTGDR -441T/C were not associated with the susceptibility for asthma (LTC4S, AA versus AC+CC, adjusted odds ratio of 0.98 (95% confidence interval, 0.73-1.31); PTGDR, TT versus TC+CC, adjusted odds ratio of 0.90 (95% confidence interval, 0.68-1.19)) or clinical phenotypes (P-value>0.05). The effects of the PTGDR and LTC4S polymorphisms on the enhancement of eosinophil counts were additive in the Korean children with asthma. In addition, the PTGDR polymorphism seems to be associated with the responsiveness to LTRA. Therefore, therapies that target the PTGDR may be useful for modulating the responsiveness to LTRA.
Similar articles
-
Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).Clin Exp Allergy. 2007 Oct;37(10):1487-93. doi: 10.1111/j.1365-2222.2007.02795.x. Clin Exp Allergy. 2007. PMID: 17883728
-
Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction.Pharmacogenet Genomics. 2008 Jul;18(7):551-8. doi: 10.1097/FPC.0b013e3282fe94c5. Pharmacogenet Genomics. 2008. PMID: 18551035 Clinical Trial.
-
TBXA2R gene polymorphism and responsiveness to leukotriene receptor antagonist in children with asthma.Clin Exp Allergy. 2008 Jan;38(1):51-9. doi: 10.1111/j.1365-2222.2007.02874.x. Epub 2007 Nov 21. Clin Exp Allergy. 2008. PMID: 18031559 Clinical Trial.
-
The prostaglandin D2 receptor (PTGDR) gene in asthma and allergic diseases.Allergol Immunopathol (Madr). 2014 Jan-Feb;42(1):64-8. doi: 10.1016/j.aller.2012.12.002. Epub 2013 Feb 12. Allergol Immunopathol (Madr). 2014. PMID: 23410912 Review.
-
Review of recent results of montelukast use as a monotherapy in children with mild asthma.Clin Ther. 2008;30 Spec No:1026-35. doi: 10.1016/j.clinthera.2008.05.018. Clin Ther. 2008. PMID: 18640477 Review.
Cited by
-
The pharmacogenetics and pharmacogenomics of asthma therapy.Pharmacogenomics J. 2011 Dec;11(6):383-92. doi: 10.1038/tpj.2011.46. Epub 2011 Oct 11. Pharmacogenomics J. 2011. PMID: 21987090 Free PMC article. Review.
-
Asthma Pharmacogenomics: 2015 Update.Curr Allergy Asthma Rep. 2015 Jul;15(7):42. doi: 10.1007/s11882-015-0544-y. Curr Allergy Asthma Rep. 2015. PMID: 26143396 Review.
-
Pharmacogenomics of Leukotriene Modifiers: A Systematic Review and Meta-Analysis.J Pers Med. 2022 Jun 29;12(7):1068. doi: 10.3390/jpm12071068. J Pers Med. 2022. PMID: 35887565 Free PMC article.
-
A review of recent advances in gene therapy, pharmacogenomics, and genetic polymorphisms in asthma.Mol Biol Rep. 2025 May 29;52(1):513. doi: 10.1007/s11033-025-10625-w. Mol Biol Rep. 2025. PMID: 40439783 Review.
-
Cysteinyl Leukotrienes Pathway Genes, Atopic Asthma and Drug Response: From Population Isolates to Large Genome-Wide Association Studies.Front Pharmacol. 2016 Dec 1;7:299. doi: 10.3389/fphar.2016.00299. eCollection 2016. Front Pharmacol. 2016. PMID: 27990118 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous